543 related articles for article (PubMed ID: 25474541)
1. Quantitative proteomics of kinase inhibitor targets and mechanisms.
Daub H
ACS Chem Biol; 2015 Jan; 10(1):201-12. PubMed ID: 25474541
[TBL] [Abstract][Full Text] [Related]
2. Characterisation of kinase-selective inhibitors by chemical proteomics.
Daub H
Biochim Biophys Acta; 2005 Dec; 1754(1-2):183-90. PubMed ID: 16198161
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of kinase inhibitor selectivity by chemical proteomics.
Daub H; Godl K; Brehmer D; Klebl B; Müller G
Assay Drug Dev Technol; 2004 Apr; 2(2):215-24. PubMed ID: 15165517
[TBL] [Abstract][Full Text] [Related]
4. Unexpected off-targets and paradoxical pathway activation by kinase inhibitors.
Hantschel O
ACS Chem Biol; 2015 Jan; 10(1):234-45. PubMed ID: 25531586
[TBL] [Abstract][Full Text] [Related]
5. Extending kinome coverage by analysis of kinase inhibitor broad profiling data.
Jacoby E; Tresadern G; Bembenek S; Wroblowski B; Buyck C; Neefs JM; Rassokhin D; Poncelet A; Hunt J; van Vlijmen H
Drug Discov Today; 2015 Jun; 20(6):652-8. PubMed ID: 25596550
[TBL] [Abstract][Full Text] [Related]
6. The design, annotation, and application of a kinase-targeted library.
Xi H; Lunney EA
Methods Mol Biol; 2011; 685():279-91. PubMed ID: 20981529
[TBL] [Abstract][Full Text] [Related]
7. New affinity probe targeting VEGF receptors for kinase inhibitor selectivity profiling by chemical proteomics.
Ku X; Heinzlmeir S; Helm D; Médard G; Kuster B
J Proteome Res; 2014 May; 13(5):2445-52. PubMed ID: 24712744
[TBL] [Abstract][Full Text] [Related]
8. Chemical proteomics and functional proteomics strategies for protein kinase inhibitor validation and protein kinase substrate identification: applications to protein kinase CK2.
Gyenis L; Turowec JP; Bretner M; Litchfield DW
Biochim Biophys Acta; 2013 Jul; 1834(7):1352-8. PubMed ID: 23416530
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in the discovery of small molecule inhibitors of interleukin-1 receptor-associated kinase 4 (IRAK4) as a therapeutic target for inflammation and oncology disorders.
Chaudhary D; Robinson S; Romero DL
J Med Chem; 2015 Jan; 58(1):96-110. PubMed ID: 25479567
[TBL] [Abstract][Full Text] [Related]
10. Small molecule substrate phosphorylation site inhibitors of protein kinases: approaches and challenges.
Breen ME; Soellner MB
ACS Chem Biol; 2015 Jan; 10(1):175-89. PubMed ID: 25494294
[TBL] [Abstract][Full Text] [Related]
11. SnapShot: Kinase Inhibitors I.
Wang J; Gray NS
Mol Cell; 2015 May; 58(4):708.e1. PubMed ID: 26000854
[TBL] [Abstract][Full Text] [Related]
12. SnapShot: Kinase Inhibitors II.
Wang J; Gray NS
Mol Cell; 2015 May; 58(4):710.e1. PubMed ID: 26000855
[TBL] [Abstract][Full Text] [Related]
13. 25 years of small molecular weight kinase inhibitors: potentials and limitations.
Fabbro D
Mol Pharmacol; 2015 May; 87(5):766-75. PubMed ID: 25549667
[TBL] [Abstract][Full Text] [Related]
14. Selective and potent small-molecule inhibitors of PI3Ks.
Jeong Y; Kwon D; Hong S
Future Med Chem; 2014 May; 6(7):737-56. PubMed ID: 24941870
[TBL] [Abstract][Full Text] [Related]
15. Application of Free-Wilson selectivity analysis for combinatorial library design.
Sciabola S; Stanton RV; Johnson TL; Xi H
Methods Mol Biol; 2011; 685():91-109. PubMed ID: 20981520
[TBL] [Abstract][Full Text] [Related]
16. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
[TBL] [Abstract][Full Text] [Related]
17. Chemical proteomics identifies unanticipated targets of clinical kinase inhibitors.
Peters EC; Gray NS
ACS Chem Biol; 2007 Oct; 2(10):661-4. PubMed ID: 18041816
[TBL] [Abstract][Full Text] [Related]
18. Proteomics analysis of cellular imatinib targets and their candidate downstream effectors.
Breitkopf SB; Oppermann FS; Keri G; Grammel M; Daub H
J Proteome Res; 2010 Nov; 9(11):6033-43. PubMed ID: 20866107
[TBL] [Abstract][Full Text] [Related]
19. Leveraging Structural Diversity and Allosteric Regulatory Mechanisms of Protein Kinases in the Discovery of Small Molecule Inhibitors.
Verkhivker GM
Curr Med Chem; 2017; 24(42):4838-4872. PubMed ID: 27719654
[TBL] [Abstract][Full Text] [Related]
20. Advancing the kinase field: new targets and second generation inhibitors.
Laufer S; Bajorath J
J Med Chem; 2015 Jan; 58(1):1. PubMed ID: 25490234
[No Abstract] [Full Text] [Related]
[Next] [New Search]
